PL1890695T3 - Zastosowanie 2,5-dipodstawionych pochodnych tiazol-4-onu w lekach - Google Patents
Zastosowanie 2,5-dipodstawionych pochodnych tiazol-4-onu w lekachInfo
- Publication number
- PL1890695T3 PL1890695T3 PL06753682T PL06753682T PL1890695T3 PL 1890695 T3 PL1890695 T3 PL 1890695T3 PL 06753682 T PL06753682 T PL 06753682T PL 06753682 T PL06753682 T PL 06753682T PL 1890695 T3 PL1890695 T3 PL 1890695T3
- Authority
- PL
- Poland
- Prior art keywords
- drugs
- derivatives
- disubstituted thiazol
- thiazol
- disubstituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/34—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/54—Nitrogen and either oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Addiction (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Anesthesiology (AREA)
- Psychology (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Ophthalmology & Optometry (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Dermatology (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102005024012A DE102005024012A1 (de) | 2005-05-20 | 2005-05-20 | Verwendung von 2,5-disubstituierten Thiazol-4-on-Derivaten in Arzneimitteln |
EP06753682A EP1890695B1 (de) | 2005-05-20 | 2006-05-17 | Verwendung von 2,5-disubstituierten thiazol-4-on-derivaten in arzneimitteln |
PCT/EP2006/004666 WO2006122777A2 (de) | 2005-05-20 | 2006-05-17 | Verwendung von 2,5-disubstituierten thiazol-4-on-derivaten in arzneimitteln |
Publications (1)
Publication Number | Publication Date |
---|---|
PL1890695T3 true PL1890695T3 (pl) | 2013-05-31 |
Family
ID=36997851
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL06753682T PL1890695T3 (pl) | 2005-05-20 | 2006-05-17 | Zastosowanie 2,5-dipodstawionych pochodnych tiazol-4-onu w lekach |
Country Status (8)
Country | Link |
---|---|
US (1) | US20090215758A1 (pl) |
EP (1) | EP1890695B1 (pl) |
JP (1) | JP5421589B2 (pl) |
CA (1) | CA2609002A1 (pl) |
DE (1) | DE102005024012A1 (pl) |
ES (1) | ES2402200T3 (pl) |
PL (1) | PL1890695T3 (pl) |
WO (1) | WO2006122777A2 (pl) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102007040336A1 (de) * | 2007-08-27 | 2009-03-05 | Johann Wolfgang Goethe-Universität Frankfurt am Main | Neue Inhibitoren der 5-Lipoxygenase und deren Verwendungen |
CL2009000294A1 (es) * | 2008-02-08 | 2009-10-23 | Shlorion Pharma Inc | Compuestos derivados de heterociclos aril metilideno; composicion farmaceutica que los comprende; y uso en el tratamiento del dolor neuropatico e inflamacion. |
US8349852B2 (en) | 2009-01-13 | 2013-01-08 | Novartis Ag | Quinazolinone derivatives useful as vanilloid antagonists |
EP2531510B1 (en) | 2010-02-01 | 2014-07-23 | Novartis AG | Pyrazolo[5,1b]oxazole derivatives as crf-1 receptor antagonists |
AR080056A1 (es) | 2010-02-01 | 2012-03-07 | Novartis Ag | Derivados de ciclohexil-amida como antagonistas de los receptores de crf |
ES2527849T3 (es) | 2010-02-02 | 2015-01-30 | Novartis Ag | Derivados de ciclohexilamida como antagonistas del receptor de CRF |
WO2016129583A1 (ja) | 2015-02-09 | 2016-08-18 | 国立大学法人岡山大学 | 乳酸脱水素酵素阻害剤およびそれを含有する抗てんかん剤 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1548312A (pl) * | 1967-06-06 | 1968-12-06 | ||
JP3871354B2 (ja) * | 1994-07-29 | 2007-01-24 | 株式会社フジモト・コーポレーション | 新規な2−(n−シアノイミノ)チアゾリジン−4−オン誘導体 |
JP3884096B2 (ja) * | 1995-10-13 | 2007-02-21 | 株式会社フジモト・コーポレーション | 新規な2−(n−シアノイミノ)チアゾリジン−4−オン誘導体 |
SE9701304D0 (sv) * | 1997-04-09 | 1997-04-09 | Astra Pharma Prod | Compounds |
TR200101208T2 (tr) * | 1998-11-03 | 2001-10-22 | Glaxo Group Limited | Seçici COX-2 inhibitörleri olarak pirazolopiridin türevleri |
PL373128A1 (pl) * | 2002-01-07 | 2005-08-22 | Pharmacia Corporation | Leczenie bólu, zapalenia i zaburzeń związanych z zapaleniem z zastosowaniem kombinacji selektywnegoinhibitora cyklooksygenazy-2 i aspiryny |
JP2006517234A (ja) * | 2003-02-10 | 2006-07-20 | アムジエン・インコーポレーテツド | バニロイド受容体リガンドおよび治療におけるこれらのリガンドの使用 |
KR20080032096A (ko) * | 2005-07-21 | 2008-04-14 | 베타게논 에이비 | 유리지방산에 의해 야기되는 질환에 사용되는 티아졸유도체 및 유사체의 용도 |
-
2005
- 2005-05-20 DE DE102005024012A patent/DE102005024012A1/de not_active Withdrawn
-
2006
- 2006-05-17 JP JP2008511622A patent/JP5421589B2/ja not_active Expired - Fee Related
- 2006-05-17 US US11/915,156 patent/US20090215758A1/en not_active Abandoned
- 2006-05-17 PL PL06753682T patent/PL1890695T3/pl unknown
- 2006-05-17 EP EP06753682A patent/EP1890695B1/de not_active Not-in-force
- 2006-05-17 ES ES06753682T patent/ES2402200T3/es active Active
- 2006-05-17 CA CA002609002A patent/CA2609002A1/en not_active Abandoned
- 2006-05-17 WO PCT/EP2006/004666 patent/WO2006122777A2/de active Search and Examination
Also Published As
Publication number | Publication date |
---|---|
DE102005024012A1 (de) | 2006-11-23 |
EP1890695B1 (de) | 2013-02-20 |
WO2006122777A3 (de) | 2007-02-22 |
ES2402200T3 (es) | 2013-04-29 |
WO2006122777A2 (de) | 2006-11-23 |
JP2008540595A (ja) | 2008-11-20 |
CA2609002A1 (en) | 2006-11-23 |
US20090215758A1 (en) | 2009-08-27 |
JP5421589B2 (ja) | 2014-02-19 |
EP1890695A2 (de) | 2008-02-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2157093A4 (en) | HETEROCYCLIC PYRROLO-NITROGEN-DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL USE | |
IL185484A0 (en) | Aminopyrazole derivatives, their manufacture and use as pharmaceutical agents | |
IL192184A0 (en) | Heterocyclic derivatives and pharmaceutical compositions containing the same | |
IL178402A0 (en) | 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof | |
IL192298A (en) | Heterocyclic Compounds, Their Acceptable Salts, Pharmaceuticals Containing and Using Them | |
ZA200606974B (en) | Substituted 1,2,3,4-tetrahydrolsoquinoline derivatives | |
IL191907A0 (en) | Azepinoindole derivatives as pharmaceutical agents | |
ZA200700705B (en) | 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof | |
IL187392A0 (en) | Thiazole derivatives, their preparation and use | |
IL180682A0 (en) | N-hydroxamide derivatives, their preparation and use | |
IL182624A0 (en) | 2-amido-4 phenylthiazole derivatives, the preparation and the therapeutic use thereof | |
IL180770A0 (en) | Oxopiperidine derivatives, preparation and therapeutic use thereof | |
IL187534A0 (en) | Thiazole derivatives, use thereof and pharmaceutical compositions containing them | |
EP1961753A4 (en) | DERIVATIVES OF PIRAZOLOPYRIMIDINONE, THEIR PREPARATION AND USE | |
IL180797A0 (en) | Amino-tropane derivatives, preparation thereof and therapeutic use thereof | |
IL184008A0 (en) | 4-cycloalkyl-substituted tetrahydrochinoline derivatives and use thereof as medicaments | |
PL1890695T3 (pl) | Zastosowanie 2,5-dipodstawionych pochodnych tiazol-4-onu w lekach | |
ZA200708813B (en) | Abtibacterial 3',5-disubstituted 2,4'-dihydroxybiphenyl compounds,derivatives and related methods | |
EP2025667A4 (en) | 9, 10-SECOPREGNANDERIVAT AND MEDICINAL PRODUCTS | |
IL190519A0 (en) | 6-heteroarylpyridoindolone derivatives, their preparation and therapeutic use thereof | |
IL177301A0 (en) | Heterocyclyl-substituted hydroxy-6-phenylphenanthridine derivatives and pharmaceutical compositions containing the same | |
IL190334A0 (en) | Pyridylsulfonamide derivatives, their manufacture and use as antineoplastic agents | |
IL186851A0 (en) | Styrylsulfonamides, their manufacture and use as pharmaceutical agents | |
IL188185A0 (en) | Phenylpyridine derivatives, their manufacture and use as pharmaceutical agents | |
IL191892A0 (en) | 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof |